Head of Platform

Sorry, this job was removed at 08:48 p.m. (CST) on Wednesday, Sep 03, 2025
Easy Apply
Be an Early Applicant
Boston, MA
In-Office
Biotech
The Role

About VantAI:

VantAI combines cutting-edge machine learning with deep systems biology, physics and chemistry expertise to solve the most challenging problems in drug discovery. We specialize in the discovery of compounds and biologics that modulate complex protein-protein interactions, using data-driven modeling approaches. Our machine learning-powered in silico platform has helped leading biopharma partners advance their development programs at a fraction of the time and cost of traditional methods.

About the role:

We're looking for a Head of Platform, a leader with a deep understanding of proteomics and small molecule drug discovery who can help us scale one of the most exciting screening and data generation platforms in a novel modality. Join us!

Key Responsibilities: 

  • Drive the scientific strategy, aligning our proteomics research with AI-driven drug discovery initiatives.
  • Lead and nurture a team of PhD researchers, promoting a culture of innovation and discovery.
  • Oversee lab operations and facilities, maintaining an environment that fosters excellence and safety.
  • Plan and steer ambitious proteomics experiments, making key decisions to shape our scientific trajectory.
  • Prudently invest in state-of-the-art lab hardware to keep us on the cutting edge of proteomics research.
  • Bridge the gap between lab teams and computational workstreams, fostering a synergistic environment that maximizes data utility.
  • Manage and optimize the lab budget, ensuring resources are strategically allocated.
  • Provide regular updates on scientific progress, keeping stakeholders informed and inspired.

 Required Qualifications:

  • PhD in Chemical Biology, Proteomics, or related field.
  • Proven experience in proteomics research and small molecule drug discovery. 
  • Track record in designing and executing complex scientific experiments.
  • 5+ years in industry experience focused on small molecule drug discovery at pharmaceutical or biotech companies, with a track record in leading small molecule proteomic initiatives. 
  • Computational affinity, worked with computational biologists.
  • Experience in managing a team of PhD researchers.
  • Familiarity with AI applications in proteomics and drug discovery.
  • Strong budget management skills.
  • Excellent communication skills, adept at summarizing scientific progress for various audiences.

Desired Skills:

  • Experience in a high-tech or AI-driven company.
  • Understanding of computational biology or bioinformatics.
  • Proven track record in setting up new labs or expanding existing facilities.

NYC Salary: $200,000 - $225,000+

This band is a reflection of the job description as written. Looking for a higher salary? Apply anyway! We are happy to speak to more experienced candidates who may require a higher salary and discuss that experience in our first touchpoint.

Similar Jobs

Aptos Labs Logo Aptos Labs

Head of Business Development – Shelby Platform

Blockchain • Internet of Things • Cryptocurrency • NFT • Web3
Easy Apply
Remote or Hybrid
US
135 Employees
In-Office
3 Locations
58848 Employees
185K-400K Annually

MassMutual Logo MassMutual

Head of SAP Platform

Big Data • Fintech • Information Technology • Insurance • Financial Services
Hybrid
Springfield, MA, USA
6000 Employees
185K-243K Annually

Origin Logo Origin

Head Of Product

Financial Services
In-Office
Boston, MA, USA
176 Employees
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: New York, New York
63 Employees
Year Founded: 2019

What We Do

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.

Similar Companies Hiring

Formation Bio Thumbnail
Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account